← Open Payments lookup

RACHEL AGUSTINES: Open Payments

NPI 1386617306 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,252 in 207 payments from 20 companies in 2025. Trend: 2023 $3,596 · 2024 $3,139 · 2025 $4,252

Food & beverage: $4,252
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.33$610
Axsome Therapeutics, Inc.19$570
Neurocrine BioSciences, Inc.17$430
Otsuka America Pharmaceutical, Inc.17$337
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$323
E.R. Squibb & Sons, L.L.C.11$260
Teva Pharmaceuticals USA, Inc.24$260
Noven Therapeutics, LLC12$232
Takeda Pharmaceuticals U.S.A., Inc.12$218
ABBVIE INC.7$191

Products named: Qelbree, Auvelity, INGREZZA, REXULTI, CAPLYTA, COBENFY, Xelstrym, AUSTEDO XR.

Industry payments across FL — which companies pay providers there.